Free Trial

Acelyrin (SLRN) SEC Filings & 10K Form

Acelyrin logo
$2.63 +0.09 (+3.54%)
As of 01:49 PM Eastern

Recent Acelyrin SEC Filings

DateFilerForm TypeView
03/25/2025
5:06 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
03/19/2025
5:06 PM
Acelyrin (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
5:11 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:55 PM
Acelyrin (Issuer)
Mpofu Shephard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:32 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
03/19/2025
3:12 PM
Acelyrin (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2025
5:02 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
03/14/2025
8:04 PM
Acelyrin (Subject)
Kim Mina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
8:37 AM
Acelyrin (Filer)
Form 8-A12B
03/13/2025
8:32 AM
Acelyrin (Subject)
Form 425
03/13/2025
8:12 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
4:58 PM
Acelyrin (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D/A
03/07/2025
11:49 AM
Acelyrin (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
03/06/2025
10:55 AM
Acelyrin (Subject)
Trium Capital LLP (Filed by)
Form SCHEDULE 13D
03/06/2025
5:03 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
03/06/2025
5:03 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
5:05 AM
Acelyrin (Subject)
Form 425
03/04/2025
8:05 AM
Acelyrin (Subject)
Form 425
03/04/2025
8:07 AM
Acelyrin (Subject)
Form 425
03/04/2025
8:12 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
02/27/2025
6:02 PM
Acelyrin (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D/A
02/21/2025
5:03 AM
Acelyrin (Subject)
Form 425
02/14/2025
5:13 PM
Acelyrin (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:45 AM
Acelyrin (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
02/10/2025
3:08 PM
Acelyrin (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SCHEDULE 13G/A
02/07/2025
4:00 PM
Acelyrin (Subject)
Form 425
02/07/2025
3:07 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
02/06/2025
7:36 PM
Acelyrin (Subject)
Form 425
02/06/2025
8:09 PM
Acelyrin (Subject)
Form 425
02/06/2025
8:40 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
02/06/2025
4:22 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
02/06/2025
4:19 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
4:21 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
01/31/2025
3:26 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
5:02 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
5:05 PM
Acelyrin (Issuer)
Mpofu Shephard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
4:58 PM
Acelyrin (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:34 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
4:17 PM
Acelyrin (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2024
11:15 PM
Acelyrin (Filer)
Form EFFECT
11/22/2024
4:41 PM
Acelyrin (Issuer)
Murugan Amar (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
While Markets Slide, These "Genesis Cog" Trades Are Up Double-Digits (Ad)

While most investors are struggling in today's volatile market, a small group of traders are quietly booking consistent gains. Just last week, our Genesis Cog subscribers captured an 11.51% gain shorting JEF, another 8.57% on CAKE, and 4.78% on RJF—all while the broader indexes continued their downward trend.

Click here to discover how the Genesis Cog works in falling markets
11/13/2024
4:26 PM
Acelyrin (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/13/2024
3:01 PM
Acelyrin (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
11:13 AM
Acelyrin (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
1:17 PM
Acelyrin (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
11/04/2024
9:56 AM
Acelyrin (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/24/2024
1:02 PM
Acelyrin (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
09/10/2024
12:49 PM
Acelyrin (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SC 13G
09/04/2024
7:36 PM
Acelyrin (Issuer)
Labrucherie Gil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:18 PM
Acelyrin (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:14 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
8:40 AM
Acelyrin (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/19/2024
5:18 PM
Acelyrin (Issuer)
Becker Daniel J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
8:07 PM
Acelyrin (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:04 PM
Acelyrin (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:07 PM
Acelyrin (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:09 PM
Acelyrin (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:11 PM
Acelyrin (Issuer)
Gosebruch Henry O (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:14 PM
Acelyrin (Issuer)
Becker Daniel J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:17 PM
Acelyrin (Issuer)
COZADD BRUCE C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:03 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:20 PM
Acelyrin (Filer)
Form 8-K/A
05/24/2024
5:59 PM
Acelyrin (Issuer)
Labrucherie Gil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:06 PM
Acelyrin (Issuer)
Gloria Melanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:10 PM
Acelyrin (Issuer)
Mpofu Shephard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:12 PM
Acelyrin (Issuer)
Pangali Sanam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:09 PM
Acelyrin (Issuer)
Pangali Sanam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:09 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:12 PM
Acelyrin (Issuer)
Gloria Melanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:05 PM
Acelyrin (Issuer)
Pangali Sanam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/17/2024
6:08 PM
Acelyrin (Issuer)
Mpofu Shephard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
7:14 AM
Acelyrin (Filer)
Form DEFA14A
05/09/2024
7:13 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
3:10 PM
Acelyrin (Filer)
Form DEF 14A
04/22/2024
3:14 PM
Acelyrin (Filer)
Form DEFA14A
04/22/2024
3:19 PM
Acelyrin (Filer)
Form ARS
04/03/2024
5:18 PM
Acelyrin (Issuer)
Lin Shao-Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:43 PM
Acelyrin (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2024
3:08 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SLRN) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners